National Bleeding Disorder Foundation (FKA National Hemophilia Foundation)
Nonprofit supporting patients with inheritable bleeding disorders.
Based in NY
🤖
AI Overview
With $1.2M in lobbying spend across 24 quarterly filings, National Bleeding Disorder Foundation (FKA National Hemophilia Foundation) is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2020 to 2025.
$1.2M
Total Spend
6
Years Active
1
Firms Hired
4
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $153K |
| 2021 | $204K |
| 2022 | $203K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Insurance, Pharmacy, MED and 1 more
- •Reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services
- •Medicare Coverage and Reimbursement of drugs
- •M
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.